PALEXIA SR

Prolonged-release tablet, 50mg
RxActive license

Active substance (INN)

tapentadol

Pharmaceutical form

Pharmaceutical formProlonged-release tablet
Strength50mg
PackagingUkupno 30 tableta sa produženim oslobađanjem u blisteru djeljivom na pojedinačne doze (3x10) u kartonskoj kutiji
ManufacturerGruenenthal GmbH, Germany
Therapeutic groupNervous system (N02AX06)
Marketing authorization holderHEMOFARM A.D. VRŠAC P.J. PODGORICA
Authorization dateJuly 23, 2024

Analogs in Montenegro

4

Other medicines with the same active substance

PALEXIARx
Film-coated tablet, 50mgGruenenthal GmbH
PALEXIARx
Film-coated tablet, 100mgGruenenthal GmbH
PALEXIA SRRx
Prolonged-release tablet, 100mgGruenenthal GmbH
PALEXIA SRRx
Prolonged-release tablet, 150mgGruenenthal GmbH
Source: CInMED register